Adaptation of a deprescription intervention to the medication management of older people living in long-term care facilities

References

• Machado-Alba JE, Gaviria-Mendoza A, Machado-Duque ME, et al. Deprescribing: a new goal focused on the patient. Expert Opin Drug Saf. 2017;16:111–112.
   PubMed Web of Science ®Google Scholar
• Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254–1268.
   PubMed Web of Science ®Google Scholar
• Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648–1654.
   PubMed Web of Science ®Google Scholar
• By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227–2246.
   PubMed Web of Science ®Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–218.
   PubMed Web of Science ®Google Scholar
• Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175:827–834.
   PubMed Web of Science ®Google Scholar
• Pottie K, Thompson W, Davies S, et al. Deprescribing benzodiazepine receptor agonists: evidence-basedclinical practice guideline. Can Fam Physician. 2018;64:339–351.
   PubMed Web of Science ®Google Scholar
• Reeve E, Farrell B, Thompson W, et al. Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine. 2018:1–14. [cited 2019 May 30]. Available from http://sydney.edu.au/medicine/cdpc/resources/deprescribing-guidelines.php
   Google Scholar
• Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for BPSD and insomnia. Can Fam Physician. 2018;64:17–27.
   PubMed Web of Science ®Google Scholar
• Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017;63:354–364.
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug burden index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68:97–105.
   PubMed Web of Science ®Google Scholar
• Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113–121.
   PubMed Web of Science ®Google Scholar
• Onder G, Marengoni A. Polypharmacy. JAMA. 2017;318:1728.
   PubMedGoogle Scholar
• Bradley MC, Fahey T, Cahir C, et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland enhanced prescribing database. Eur J Clin Pharmacol. 2012;68:1425–1433.
   PubMed Web of Science ®Google Scholar
• Cahir C, Fahey T, Teeling M, et al. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69:543–552.
   PubMed Web of Science ®Google Scholar
• Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3–11.
   PubMed Web of Science ®Google Scholar
• Reeve E, Moriarty F, Nahas R, et al. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert Opin Drug Saf. 2018;17:39–49.
   PubMed Web of Science ®Google Scholar
• Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9:CD008165.
   PubMedGoogle Scholar
• Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–184.
   PubMed Web of Science ®Google Scholar
• Pottie K, Farrell B, Haydt S, et al. Integrating pharmacists into family practice teams: physicians’ perspectives on collaborative care. Can Fam Physician. 2008;54:1714–1717.
   PubMed Web of Science ®Google Scholar
• Moriarty F, Pottie K, Dolovich L, et al. Deprescribing recommendations: an essential consideration for clinical guideline developers. Res Social Adm Pharm. 2019;15:806–810.
   Web of Science ®Google Scholar
• Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25:1021–1031.
   PubMed Web of Science ®Google Scholar
• Mokhar A, Tillenburg N, Dirmaier J, et al. Potentially inappropriate use of benzodiazepines and z-drugs in the older population-analysis of associations between long-term use and patient-related factors. PeerJ. 2018;6:e4614.
   PubMed Web of Science ®Google Scholar
• Garre-Olmo J, Planas-Pujol X, López-Pousa S, et al. Cross-cultural adaptation and psychometric validation of a Spanish version of the quality of life in late-stage dementia scale. Qual Life Res. 2010;19:445–453.
   PubMed Web of Science ®Google Scholar
• Reisberg B, Torossian C, Shulman MB, et al. Two year outcomes, cognitive and behavioral markers of decline in healthy, cognitively normal older persons with global deterioration scale stage 2 (subjective cognitive decline with impairment). J Alzheimers Dis. 2019;67:685–705.
   PubMed Web of Science ®Google Scholar
• Miguélez M, Merlani P, Gigon F, et al. Feasibility of a multiple-choice mini mental state examination for chronically critically ill patients. Crit Care Med. 2014;42:1874–1881.
   PubMed Web of Science ®Google Scholar
• Guerin JM, Copersino ML, Schretlen DJ. Clinical utility of the 15-item geriatric depression scale (GDS-15) for use with young and middle-aged adults. J Affect Disord. 2018;241:59–62.
   PubMed Web of Science ®Google Scholar
• Beer C, Loh P-K, Peng YG, et al. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf. 2011;2:37–43.
   PubMedGoogle Scholar
• Declercq T, Petrovic M, Azermai M, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;3:CD007726.
   PubMed Web of Science ®Google Scholar
• Ballard C, Lana MM, Theodoulou M, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med. 2008;5:87–99.
   Web of Science ®Google Scholar
• Ruths S, Straand J, Nygaard HA, et al. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study–the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry. 2008;23:889–895.
   PubMed Web of Science ®Google Scholar
• Saraf AA, Peterson AW, Simmons SF, et al. Medications Associated with Geriatric Syndromes (MAGS) and their prevalence in older hospitalized adults discharged to skilled nursing facilities. J Hosp Med. 2016;11:694–700.
   PubMed Web of Science ®Google Scholar
• Van Reekum R, Clarke D, Conn D, et al. A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. Int Psychogeriatrics. 2002;14:197–210.
   PubMed Web of Science ®Google Scholar
• APA Work Group on Alzheimer’s Disease and other Dementias, Rabins PV, Blacker D, Rovner BW, et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer’s disease and other dementias. Am J Psychiatry. Second edition. 2007;164:5–56.
   Web of Science ®Google Scholar
• Farrell B, Richardson L, Raman-Wilms L. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines. Res Social Adm Pharm. 2018;14:18–25.
   PubMed Web of Science ®Google Scholar
• Farrell B, Ward N, Dore N. Working in interprofessional primary health care teams: what do pharmacists do? Res Social Adm Pharm. 2013;9:288–301.
   PubMed Web of Science ®Google Scholar